David L. Dunner, MD

Original Research

Differential Effects of Nefazodone and Cognitive Behavioral Analysis System of Psychotherapy on Insomnia Associated With Chronic Forms of Major Depression

June 18, 2002

Rachel Manber, David L. Dunner, Susan G. Kornstein, et al

Book Review

Clinical Handbook of Psychotropic Drugs, 11th ed., revised

March 1, 2002

David L. Dunner

Article

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

January 1, 2002

David L. Dunner, Norman Sussman, John Zajecka, et al

Original Research

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

June 1, 2001

Maurizio Fava, David L. Dunner, Madhukar H. Trivedi, et al

Article

Acute and Maintenance Treatment of Chronic Depression

May 1, 2001

David L. Dunner

Article

Acute and Maintenance Treatment of Chronic Depression

May 1, 2001

David L. Dunner

Original Research

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

February 1, 2001

David L. Dunner, Nathalie E. Richard, Rafe M. J. Donahue, et al

Book Review

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

September 30, 2000

David L. Dunner

Article

Introduction: New Strategies for Improving the Treatment of Depression

September 30, 2000

David L. Dunner

Article

Introduction: New Strategies for Improving the Treatment of Depression

September 30, 2000

David L. Dunner

Article

Optimizing Lithium Treatment

July 31, 2000

David L. Dunner

Original Research

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

November 30, 1999

David L. Dunner, Peter P. Roy-Byrne, Deborah S. Cowley, et al

Differential Effects of Nefazodone and Cognitive Behavioral Analysis System of Psychotherapy on Insomnia Associated With Chronic Forms of Major Depression

Clinical Handbook of Psychotropic Drugs, 11th ed., revised

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Acute and Maintenance Treatment of Chronic Depression

Acute and Maintenance Treatment of Chronic Depression

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

Introduction: New Strategies for Improving the Treatment of Depression

Introduction: New Strategies for Improving the Treatment of Depression

Optimizing Lithium Treatment

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

ELSEWHERE:

FOLLOW US:

David L. Dunner, MD

Differential Effects of Nefazodone and Cognitive Behavioral Analysis System of Psychotherapy on Insomnia Associated With Chronic Forms of Major Depression

Clinical Handbook of Psychotropic Drugs, 11th ed., revised

Six-Year Perspectives on the Safety and Tolerability of Nefazodone

Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial

Acute and Maintenance Treatment of Chronic Depression

Acute and Maintenance Treatment of Chronic Depression

Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression

Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders

Introduction: New Strategies for Improving the Treatment of Depression

Introduction: New Strategies for Improving the Treatment of Depression

Optimizing Lithium Treatment

Relationship Between Borderline Personality Disorder and Axis I Diagnosis in Severity of Depression and Anxiety

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles